Matthew E. Monaghan


Matthew E. Monaghan is an independent director who joined our Board in October 2016 and serves as Chair of the Nominating and Corporate Governance Committee and is a member of the Audit Committee. Mr. Monaghan served as President, Chief Executive Officer and Chair of the Board at Invacare Corporation (NYSE:IVC), a medical device manufacturer for the home and long-term healthcare markets, for more than seven years from 2015 until August 2022. He previously served as Senior Vice President and General Manager, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. (formerly known as Zimmer Holdings, Inc.) (NYSE:ZBH), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products from 2014 to 2015. Mr. Monaghan also has served as Operating Executive for Texas Pacific Group from 2006 to 2009 and at Cerberus Capital Management from 2003 to 2005. He started his career with 13 years in the aerospace, medical and other industrial businesses of General Electric.

Mr. Monaghan served on the board of directors of Invacare Corporation from 2015 to 2022. He was a trustee of Cleveland Clinic Avon Lake Hospital from 2016 to 2021. Mr. Monaghan was a member of the board of directors of CD Diagnostics, Inc. from 2012 to 2016 and served as the chairman of the Audit Committee from 2012 to 2015 and as chairman of the board from 2015 to 2016. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD Business School in France.